The U.S. Supreme Court Monday declined to hear Gilead Sciences Inc. v. U.S., Ex Rel. Campie. The decision to deny cert is the end of the road for the whistleblower case, and it leaves standing a Ninth Circuit decision that the government's continued approval and payment for products after learning of alleged regulatory infractions doesn't foreclose False Claims Act allegations.